Cargando…
Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation
Type I diabetes (T1D), mediated by autoreactive T cell destruction of insulin-producing islet beta cells, has been treated with bone marrow-derived hematopoietic stem cell (BM-HSC) transplantation. Older non-obese diabetic (NOD) mice recipients (3m, at disease-onset stage) receiving syngeneic BM-HSC...
Autores principales: | Wang, Nan, Rajasekaran, Narendiran, Hou, Tieying, Macaubas, Claudia, Mellins, Elizabeth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447290/ https://www.ncbi.nlm.nih.gov/pubmed/26020954 http://dx.doi.org/10.1371/journal.pone.0128494 |
Ejemplares similares
-
Multicohort Analysis Identifies Monocyte Gene Signatures to Accurately Monitor Subset-Specific Changes in Human Diseases
por: Vallania, Francesco, et al.
Publicado: (2021) -
NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning
por: Verbiest, Tom, et al.
Publicado: (2016) -
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014) -
Immunologic Complications and Graft Survival in Crohn’s Disease and NOD2 Mutant Non-Crohn’s Disease Adult Recipients Following Intestine Transplantation
por: Belyayev, Leonid, et al.
Publicado: (2020) -
Immunologic monitoring in kidney transplant recipients
por: Townamchai, Natavudh, et al.
Publicado: (2013)